This site is intended for healthcare providers. If you’re a patient, please click here.

A different kind of formulation.4-9
DAXXIFY® is the first innovation in neuromodulators in 20 years, and the only one with a peptide formulation.4-9,16
How the peptide formulation works.
Enhances attachment
Our positively charged peptide forms a powerful bond with the neuron.12
Sustains delivery
This bond helps keep more of the active ingredient available over time.12
Stabilizes the active ingredient
The peptide helps stabilize the core neuromodulator—eliminating the need for human blood or animal components.4,11

Three benefits.
One unique formulation.
DAXXIFY® is fast-acting, long-lasting,
and smooths even the deepest lines
for radiant-looking results.1-4
Fast-acting
DAXXIFY® kicks in quickly.1,4 Most patients see results as early as the next day and typically within two days after treatment.1,4*
Long-lasting
DAXXIFY® is long-lasting and keeps frown lines smoother with results that slowly soften over a prolonged period.2†
Radiant-looking results
DAXXIFY® improves the appearance of skin texture, and many patients report a radiant or bright look after treatment.3‡
*In clinical trial diaries, patients reported seeing a measurable improvement within 2 days of treatment.1,2,4
†More than 50% had no or minor frown lines until 6 months after treatment, per both physician’s and patient’s assessments.10 74% achieved a ≥ 2-grade improvement at week 4 per both physician’s and patient’s assessments.2,4
‡In an open-label study (N=27), 89% of patients agreed their skin looked radiant/bright (exploratory endpoint).4 In an open label study (N=27), 96% of patients agreed their skin looked smooth in the glabella (exploratory endpoint).3
Why providers choose DAXXIFY®.
“The reaction that my patients have to the fact that [the appearance of] their skin texture is improved and the fact that they’re getting a long-lasting product has made it an elevated experience for my patients.”
– Board Certified Dermatologist
*In an open label study (N=27), 96% of patients agreed their skin looked smooth in the glabella (exploratory endpoint).3 More than 50% had no or minor frown lines until 6 months after treatment per both physician’s and patient’s assessments.4,10


Manufactured in the USA.4
DAXXIFY® is the only neuromodulator manufactured in the U.S.A.4-9
Ready to show your patients the DAXXIFY® Difference?
Contact us today to start offering DAXXIFY® at your practice.



